The Thing That Hid MetLife, Inc. (MET)’s Strength

Shares of MetLife, Inc. (NYSE:MET) recorded -2.15% loss during trading session on August 2nd, 2019. The script traded as low as $47.03 and last traded at $47.29. 8.91 million shares changed exchanged hands during trading, a drop of -97.2% from the 30-day average session volume of 4.52M shares. The firm had previously closed at $48.33. The company has $971.27M outstanding shares, a price-to-earnings ratio of 7.77, price-to-earnings-growth ratio of 0.70 and a beta of 1.09. The company has a RSI of 29.36, ATR of 0.88 and a volatility of 2.82% this week. MET has a 52 week low price of $37.76 and a 52 week high price of $51.16.

Investors have identified the tech company MetLife, Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around 45.93B, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.

MetLife, Inc. (MET) Fundamentals that are to be considered.

When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For MET, the company has in raw cash 14.51 billion on their books with 654.45 billion currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 9.42 billion total, with 0 as their total liabilities. This figure have given the company a good sense of viability under numerous contexts.

MET were able to record 2.07 billion as free cash flow during the recently reported quarter of the year, this saw their quarterly net cash flow reduce by 14.51 billion. In cash movements, the company had a total of 0 as operating cash flow.

Potential earnings growth for MetLife, Inc. (MET)

In order to determine the future investment potential for this stock, we will have to analyze key trends that affect it. During the third quarter of the year, MetLife, Inc. recorded a total of 16.3 billion in revenue. This figure implies that they witnessed a quarterly year/year change in their earnings with 0.09% coming in sequential stages and their sales for the third quarter increasing by 0.04%.

What matters though is how it ends. When the core data for the company is broken down, then the stock sounds interesting. The company spent 14.56 billion trying to sell their products during the last quarter, with the result yielding a gross income of 1.74 billion. This allows shareholders to hold on to 971.27M with the revenue now reading 0 cents per share. This is a figure that is close to analyst’s prediction for their fourth quarter (1.42 cents a share).

Is the stock of MET attractive?

Having a look at the company’s valuation, the company is expected to record 6.07 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on MET sounds very interesting.

In related news, EVP & Chief Financial Officer McCallion John D. sold 2,669 shares of the company’s stock in a transaction that recorded on February 12th, 2019. The sale was performed at an average price of 44.43, for a total value of 118,592. As the sale deal closes, the EVP & Chief Investment Officer McCallion John D. now sold 10,292 shares of the company’s stock, valued at 456,950. Also, Director GUTIERREZ CARLOS M bought 6,400 shares of the company’s stock in a deal that was recorded on December 17th, 2019. The shares were bought at an average price of 39.04 per share, with a total market value of 18,807. Following this completion of acquisition, the Chairman, President & CEO now holds 42,805 shares of the company’s stock, valued at 2,013,119. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.10%.

5 out of 19 analysts covering the stock have rated it a Buy, while 8 have maintained a Hold recommendation on MetLife, Inc. stock. 1 analysts has assigned a Sell rating on the MET stock. The 12-month mean consensus price target for the company’s shares has been set at $53.53.